Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
148
datasets available to search
ShareScore release 0.9.0
Dataset results
148 results for “Vemurafenib”
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
ClinicalTrials.gov study NCT04462471. IPD Sharing: YES. Countries: 1. Publications: 1.
Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma
ClinicalTrials.gov study NCT01597908. IPD Sharing: YES. Countries: 28. Publications: 5.
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
ClinicalTrials.gov study NCT01909453. IPD Sharing: YES. Countries: 29. Publications: 9.
S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02164916. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)
ClinicalTrials.gov study NCT01006980. IPD Sharing: Not stated. Countries: 12. Publications: 8.
Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma
ClinicalTrials.gov study NCT01673854. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
ClinicalTrials.gov study NCT01711632. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
ClinicalTrials.gov study NCT01286753. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of Vemurafenib in Participants With Metastatic Melanoma
ClinicalTrials.gov study NCT01307397. IPD Sharing: Not stated. Countries: 44. Publications: 2.
Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)
ClinicalTrials.gov study NCT01400451. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT01910181. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
ClinicalTrials.gov study NCT05068752. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma
ClinicalTrials.gov study NCT01271803. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
ClinicalTrials.gov study NCT01474551. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vemurafenib and TIL Therapy for Metastatic Melanoma
ClinicalTrials.gov study NCT02354690. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
ClinicalTrials.gov study NCT01519323. IPD Sharing: Not stated. Countries: 10. Publications: 1.
BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma
ClinicalTrials.gov study NCT01512251. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03220035. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT00949702. IPD Sharing: Not stated. Countries: 2. Publications: 5.
A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers
ClinicalTrials.gov study NCT01524978. IPD Sharing: Not stated. Countries: 6. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.